-
Vaccines Industry Witnesses Essential Demand in Efforts to Safeguard the Population Against COVID-19
prnewswire
April 10, 2020
ResearchAndMarkets.com identifies Unified Communications as one of the key industries seeing increased demand due to the Coronavirus pandemic.
-
Gilead supersizes remdesivir trials, changes primary endpoint
fiercebiotech
April 10, 2020
Gilead Sciences has made major mid-study changes to its global remdesivir trials, quadrupling the enrollment target and switching the primary endpoint.
-
Tiziana develops delivery tech for COVID-19 treatment
pharmatimes
April 10, 2020
Tiziana Life Sciences says it has developed an investigational new technology that it hopes will ultimately be used to treat COVID-19 infections.
-
Avacta and Cytiva team up for COVID-19
pharmatimes
April 10, 2020
Avacta and Cytiva (formerly known as GE Healthcare Life Sciences) have formed a collaboration to develop and manufacture an Affimer-based point-of-care rapid test intended.
-
Kedrion Biopharma to Develop Plasma-based Treatment for COVID-19
americanpharmaceuticalreview
April 10, 2020
Kedrion Biopharma has started the development of a plasma-derived therapy for treating the COVID-19 virus that could make it available to patients in as little as three to six months.
-
Cytovia, Macromoltek to Develop COVID-19 Dual-Acting Natural Killer Immunotherapy
americanpharmaceuticalreview
April 10, 2020
Cytovia Therapeutics is expanding its programs to help urgently address the current SAR CoV2 (COVID-19) crisis.
-
Akers Biosciences, Premas Biotech Announce Progress in its Vaccine Development for COVID-19
americanpharmaceuticalreview
April 10, 2020
Akers Biosciences announced its collaboration with Premas Biotech has successfully completed the milestone of obtaining clones of all three coronavirus antigens, Spike (S) ...
-
FDA warns company selling fraudulent COVID-19 products containing chlorine dioxide
europeanpharmaceuticalreview
April 10, 2020
The US Food and Drug Administration (FDA) issued the letter after finding the products contain chlorine dioxide, a powerful bleaching agent with potentially fatal side effects.
-
OncoImmune gets approval to trial CD24Fc for Covid-19 in US
pharmaceutical-technology
April 10, 2020
The US Food and Drug Administration (FDA) has approved for OncoImmune to conduct a Phase III clinical trial of CD24Fc to treat patients hospitalised with Covid-19.
-
AstraZeneca begins efforts to identify antibodies against Covid-19
pharmaceutical-technology
April 10, 2020
AstraZeneca has begun research efforts focused on the identification and development of antibody therapies against Covid-19 coronavirus infection.